Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
10592studies shown
Showing 385-396 of 10,592
Device study icon
RecruitingNCT05276050

Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)

This observational study is following people with Smoking Cessation, Nicotine Addiction, or Schizophrenia to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
Schizophrenia, AddictionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 65 Years
Countries
United States
Sponsor
The University of Texas Health Science Center, Houston
Condition
Schizophrenia, Addiction
Drug study icon
RecruitingNCT07484217

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

This observational study is following people with depression With Excessive Daytime Sleepiness Symptoms to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In United States
DepressionDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
Axsome Therapeutics, Inc.
Condition
Depression
Behavioral study icon
RecruitingNCT05656469

Clinical Study Evaluating Pharmacogenomics-informed Pharmacotherapy Versus Dosing as Usual in Psychiatric Disorders

This study is looking at whether Personalised medication advice based on pharmacogenetic testing can help people with anxiety or psychosis. Participants receive a study treatment and complete follow-up visits and assessments.

In United States
Anxiety, SchizophreniaBehavioralFrom 16 Years to 70 Years
Countries
United States, United Kingdom, Germany, ...
Sponsor
Parnassia Groep
Condition
Anxiety, Schizophrenia
Drug study icon
RecruitingNCT05824728

AGB101 for Schizophrenia

This study is recruiting in the United States. It is testing AGB101 for Schizophrenia.

In United States
SchizophreniaDrugFrom 40 Years to 85 Years
Countries
United States
Sponsor
Johns Hopkins University
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT05748730

study for Integrated Care to Help At Risk Teen (iCHART) Intervention

This study is looking at whether a digital support tool can help people with Suicide and Depression or Adolescent Behavior. Participants take part in the program and complete follow-up questionnaires or assessments.

In United States
DepressionBehavioralFrom 12 Years to 18 Years
Countries
United States
Sponsor
University of Pittsburgh
Condition
Depression
Drug study icon
RecruitingNCT05543681

study on Agitation in Alzheimer's Dementia

This summary needs review. Please check the official study record and contact the research team for details.

In United States
AnxietyDrugOver 60 Years
Countries
United States, Canada, Colombia
Sponsor
IGC Pharma, LLC
Condition
Anxiety
Other study type icon
RecruitingNCT06831968

Clinical Validation of a Predictive Test for Postpartum Depression

This study is looking at develop a blood test that may be predictive of postpartum depression for people with Postpartum Depression or Pregnancy. Participants mainly provide questionnaire, assessment, or follow-up information rather than receiving a new study treatment.

In United States
DepressionDiagnostic TestA study that looks at how to detect, measure, or better understand a condition.Over 18 Years
Countries
United States
Sponsor
University of Virginia
Condition
Depression
Device study icon
RecruitingNCT04004169

Closed-Loop Deep Brain Stimulation for Major Depression

This study is looking at test a personalized approach to brain stimulation as an intervention for depression. Participants take part in a digital support tool and complete follow-up assessments.

In United States
DepressionDeviceFrom 22 Years to 70 Years
Countries
United States
Sponsor
Andrew Krystal
Condition
Depression
Device study icon
RecruitingNCT07127913

Closed-Loop Deep Brain Stimulation for Treatment-Resistant Depression in bipolarity

This study is looking at whether a digital support tool can help people with Bipolarity II or Bipolarity II, Most Recent Episode Major Depressive. Participants take part in a digital support tool and complete follow-up assessments.

In United States
Bipolarity, DepressionDeviceFrom 22 Years to 70 Years
Countries
United States
Sponsor
Andrew Krystal
Condition
Bipolarity, Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.